Skip to content
LinkedIn
Search
Search
The Business of Biofabrication
News
Perspectives
Learn
R.D. Solorzano
May 14, 2026
Why Hypoparathyroidism May Be the Best First Market for Biofabricated Endocrine Tissue Therapeutics
R.D. Solorzano
May 13, 2026
CTIBIOTECH Lands €1.25M from France 2030 to Industrialize 3D Bioprinted Tumors, and Take Aim at Oncology’s 95% Failure Problem
R.D. Solorzano
May 8, 2026
restor3d’s Aeros Ankle System Goes Full Commercial, 3D-Printed Orthopaedics Hits the Clinic
R.D. Solorzano
May 7, 2026
Miromatrix’s miroliverELAP Earns RMAT Designation
R.D. Solorzano
May 2, 2026
Hyalex Secures 510(k) Clearance for Cartilage-Mimicking Implant, Advancing Synthetic Biomaterials into Market
R.D. Solorzano
May 1, 2026
XellSmart Launches Phase II Trial of Off-the-Shelf iPSC Cell Therapy for Parkinson’s
R.D. Solorzano
April 30, 2026
Eli Lilly Pays Up to $7B for Kelonia’s In Vivo CAR-T Platform and What It Means for Cell Therapy Manufacturing
R.D. Solorzano
April 29, 2026
OHSU Secures $9.2M NIH Grant to Advance Bone Cancer Organs-on-Chips Research
R.D. Solorzano
April 27, 2026
The Organ-on-Chip, Microphysiological Systems Landscape, NAMs: A Business Overview
R.D. Solorzano
April 24, 2026
Linton Lifesciences Launches Biofabricated NAMs: Rebuilding the Missing Layer Between Biology and Decision-Making
R.D. Solorzano
1
2
3
…
14
Next Page
Archives
Subscribe
Subscribed
The Business of Biofabrication
Sign me up
Already have a WordPress.com account?
Log in now.
The Business of Biofabrication
Subscribe
Subscribed
Sign up
Log in
Report this content
View site in Reader
Manage subscriptions
Collapse this bar
The Business of Biofabrication 